The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Metrics to compare | TOI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTOIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.7x | 6.4x | −0.5x | |
PEG Ratio | −0.29 | 0.13 | 0.00 | |
Price / Book | −21.6x | 3.3x | 2.6x | |
Price / LTM Sales | 0.7x | 1.2x | 3.2x | |
Upside (Analyst Target) | 118.7% | 41.5% | 45.7% | |
Fair Value Upside | Unlock | 5.1% | 4.8% | Unlock |